Clinical Trial Update: A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat [Phase 3]

View source ↗

Summary

Phase 3 study evaluating anti-Fel d 1 antibodies injections for cat-allergic adolescents and adults with allergic rhinitis was terminated, with results posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Anti-Fel d 1 antibodies injections (anti-Fel d 1 antibodies)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Allergic Rhinitis Due to Cat Allergy | Phase 3 | Status: TERMINATED | Results posted: 2024-06-11